Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
Is it past time for a new approach to the COVID vaccine? Ocugen Chairman of the Board, Founder & CEO Shankar Musunuri, Ph.D. says yes, and his ideals would mark significant improvements: fewer shots,...
bioprocessonline.com